...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Danishgah-i Ulum-i Pizishki va Khadamat-i Bihdashti-Darmani Shahid Sadugi Yazd. Majallah >Comparison of Hemoglobin A1c Levels in Healthy Patients and Non Diabetic Iron Deficiency Anemia(IDA) Patients Before and after Intervention in Rafsanjan
【24h】

Comparison of Hemoglobin A1c Levels in Healthy Patients and Non Diabetic Iron Deficiency Anemia(IDA) Patients Before and after Intervention in Rafsanjan

机译：Rafsanjan干预前后健康患者和非糖尿病铁缺乏性贫血（IDA）患者血红蛋白A1c水平的比较

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: Glycemia and blood glucose levels are under the effect of Hb A1c and therefore they could be considered as a valid index for the follow-up and control of diabetes .There are different and controversial reports on the effects of iron deficiency anemia on Hb A1c. Effects of IDA in non diabetic patients are also unknown. The aim of the study was the comparison of Hb A1C levels in healthy patients and non diabetic Iron deficiency anemia (IDA) patients before and after intervention in Rafsanjan.Methods: This research was a semi– experimental intervention study. The population under study consisted of 30 non diabetic IDA patients and 30 healthy patients in Rafsanjan that were matched for age and sex and other characteristics. Ferritin, Hb, HCT, MCV, MCH, MCHC, FBS, BS 2HPP and Hb A1c, were measured to confirm IDA. These parameters were also measured in the healthy subjects (control group) to confirm their health and them being non diabetic and iron sufficient and all parameters were compared after the intervention. Then all patients with IDA were treated with iron 6mg/ kg for 3 months. The tests was repeated again and results compared with the results of both the groups before the intervention.Results: The mean Hb A1c level before iron treatment was (7.64±2.08) in patients with IDA that was higher than the control group (5.97± 1.01)(p
机译：简介：血糖和血糖水平受Hb A1c影响，因此可以被认为是糖尿病随访和控制的有效指标。关于缺铁性贫血对Hb A1c的影响有不同且有争议的报道。 。 IDA在非糖尿病患者中的作用也是未知的。这项研究的目的是比较健康患者和非糖尿病铁缺乏性贫血（IDA）患者在Rafsanjan干预之前和之后的H​​b A1C水平。方法：这项研究是一项半实验性干预研究。接受研究的人群由拉夫桑詹的30名非糖尿病IDA患者和30名健康患者组成，这些患者的年龄，性别和其他特征相匹配。测量铁蛋白，Hb，HCT，MCV，MCH，MCHC，FBS，BS 2HPP和Hb Alc以确认IDA。还对健康受试者（对照组）中的这些参数进行了测量，以确认他们的健康状况，他们是否患有糖尿病且铁质是否充足，并在干预后比较了所有参数。然后所有的IDA患者接受铁6mg / kg治疗3个月。再次重复测试，结果与干预前两组结果进行比较。结果：IDA患者铁治疗前的平均Hb A1c水平为（7.64±2.08），高于对照组（5.97±1.01） ）（p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号